ici 118551 has been researched along with Anxiety Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sánchez, C | 1 |
Cooper, SJ; Gilliland, A; Kelly, CB; McGilloway, S | 1 |
Devaney, NM; Gilbert, JK; King, DJ | 1 |
2 trial(s) available for ici 118551 and Anxiety Disorders
Article | Year |
---|---|
Beta 2-adrenoceptor antagonism in anxiety.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Humans; Male; Propanolamines; Psychiatric Status Rating Scales; Single-Blind Method | 1990 |
A double-blind placebo controlled trial of a selective beta 2 adrenoceptor antagonist (ICI 118551) in chronic anxiety.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol | 1987 |
1 other study(ies) available for ici 118551 and Anxiety Disorders
Article | Year |
---|---|
Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Chlordiazepoxide; Darkness; Diazepam; Disease Models, Animal; Exploratory Behavior; Fenfluramine; Light; Male; Mice; Penbutolol; Propanolamines; Pyrimidines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |